共 47 条
[41]
Naparstek Y., Benyehuda A., Madaio M.P., Bartana R., Schuger L., Pizov G., Neeman Z., Cohen I.R., Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin, Arthritis Rheum, 33, pp. 1554-1559, (1990)
[42]
Mihara M., Ohsugi Y., Autoimmune kidney disease in MRL/Mp-lpr mice inhibited by OK-432, a streptococcal preparation, Clin Exp Immunol, 78, pp. 102-107, (1989)
[43]
Kim C., Siminovitch K.A., Ochi A., Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment, J Exp Med, 174, pp. 1431-1437, (1991)
[44]
Cavallo T., Granholm N.A., Lipopolysaccharide from gram-negative bacteria enhances polyclonal B-cell activation and exacerbates nephritis in MRL/lpr mice, Clin Exp Immunol, 82, pp. 515-521, (1990)
[45]
Ramos-Gutierrez J., Andrew J.L., Revilla Y., Vinuela M.-A.C., Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus, Nature, 346, pp. 271-274, (1990)
[46]
Hishikawa T., Tokano Y., Sekigawa I., Ando S., Takasaki Y., Hashimoto H., Hirose S., Okumura K., Abe M., Shirai T., HLA-DP + T-cells and deficient interleukin-2 production in patients with systemic lupus erythematosus, Clin Immunol Immunopathol, 55, pp. 285-296, (1990)
[47]
Engleman E.G., Sonnenfeld G., Dauphinee M., Greenspan J.S., Talal N., McDevitt H.O., Merigan T.C., Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune disease, Arthritis Rheum, 24, pp. 1396-1402, (1981)